Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Practice Point
Nature Reviews Clinical Oncology 2, 342–343 (1 July 2005) | doi:10.1038/ncponc0222
Does neoadjuvant versus adjuvant systemic treatment improve outcomes in breast cancer?
&
Abstract
Mauri D et al. (2005) Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 97: 188–194 Synopsis Background Patients with breast cancer are increasingly being treated with neoadjuvant therapy, also known as preoperative or PRIMARY MEDICAL THERAPY, mainly for breast conservation purposes.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
